The Journal of Urology
Volume 166, Issue 6 , Pages 2189-2192 , December 2001

VALIDITY OF THE PROSTATE SPECIFIC ANTIGEN TEST FOR PROSTATE CANCER SCREENING: FOLLOWUP STUDY WITH A BANK OF 21,000 SERA IN FINLAND

,Accepted 15 June 2001.

REFERENCES 

  1. Smart CR . The results of prostate carcinoma screening in the U. S. as reflected in the surveillance, epidemiology, and end results program . Cancer . 1997;80:1835
  2. Stenman U-H , Hakama M , Knekt P , et al.   Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer . Lancet . 1994;344:1594
  3. Parkes C , Wald NJ , Murphy P , et al.   Prospective observational study to assess value of prostatic specific antigen as screening test for prostate cancer . BMJ . 1995;311:1340
  4. Knekt P . Serum alpha-tocopherol and the risk of cancer . vol. 83. Helsinki: Publications of the Social Insurance Institution; 1988;
  5. Stenman U-H , Björses U-M , Leinonen J . Time-resolved immunofluorometric assay of prostate-specific antigen . J Nucl Med Allied Sci, suppl. . 1990;34:249
  6. Bangma CH , Kranse R , Blijenberg BG , et al.   Free and total prostate-specific antigen in a screened population . Br J Urol . 1997;79:756
  7. Määttänen L , Auvinen A , Stenman U-H , et al.   Three year results of the Finnish prostate cancer screening trial . J Natl Cancer Inst . 2001;93:552
  8. Mettlin CJ , Murphy GP , Rosenthal DS , et al.   The National Cancer Data Base report on prostate carcinoma after the peak incidence rates in the U . S. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer . 1998;83:1679
  9. Dennis LK , Resnick MI . Analysis of recent trends in prostate cancer incidence and mortality . Prostate . 2000;42:247
  10. Ries LAG , Eisner MP , Kosary CL , et al.   SEER Cancer Statistics Review, 1973–1997 . Bethesda: National Cancer Institute; 2000;
  11. Roberts RO , Bergstralh EJ , Katusic SK , et al.   Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted County, Minnesota . J Urol . 1999;161:529
  12. Majeed A , Babb P , Jones J , et al.   Trends in prostate cancer incidence, mortality and survival in England and Wales 1971–1998 . BJU Int . 2000;85:1058
  13. Hsing AW , Tsao L , Devesa SS . International trends and patterns of prostate cancer incidence and mortality . Int J Cancer . 2000;85:60
  14. Auvinen A , Rietbergen JB , Denis LJ , et al.   A prospective evaluation plan for randomized trials of prostate cancer screening. The International Prostate Cancer Screening Trial Evaluation Group . J Med Screen . 1996;3:97
  15. Määttänen L , Auvinen A , Stenman U-H , et al.   European randomized study of prostate cancer screening: first-year results of the Finnish trial . Br J Cancer . 1999;79:1210
  16. Miller AB , Chamberlain J , Day NE , et al.   Cancer Screening. UICC Project on Evaluation of Screening for Cancer . Cambridge: Cambridge University Press; 1991;
  17. Schröder FH , Bangma CH . The European Randomized Study of Screening for Prostate Cancer (ERSPC) . Br J Urol, suppl. . 1997;79:68

PII: S0022-5347(05)65532-2

The Journal of Urology
Volume 166, Issue 6 , Pages 2189-2192 , December 2001

Article Tools

* Image Usage & Resolution